U.S. Primary Care Physicians Market Size, Share, Growth, Trends, Company Analysis, Regional Insights and Forecast 2020 - 2027

The U.S. primary care physicians market size was valued at USD 281 billion in 2019 and is expected to grow at a CAGR of 4.7% over forecast period 2020 to 2027.

Access to primary care providers can curb the growing rate of hospitalization, usage of prescription drugs, and prevalence of chronic diseases. General physicians practicing internal medicine, family medicine, and pediatrics provide early detection of diseases with immediate treatment, management of chronic conditions, and preventive measures. Primary care is the center of the U.S. healthcare system, reforms in the healthcare coverage will reenergize the infrastructure and aid the rebuilding of the primary care payment and delivery model. The comprehensive care provided by primary care physicians (PCPs) and the continuous patient and physician relationship is essential to improve the quality of care which will lead to positive patient outcomes in the long run.

The U.S. healthcare system majorly relies on primary care doctors to lower the overall Medicare spending. Government bodies have realized the importance of primary care physicians in developing a value-based healthcare system in the U.S. and have undertaken various initiatives to bridge these gaps between revenues of different specialties. These initiatives are anticipated to empower primary care physicians to spend more time with patients rather than performing other administrative work.

The Centers for Medicare & Medicaid Services (CMS) have developed several models such as Comprehensive Primary Care Plus (CPC+) and Primary Care First Model to strengthen primary care at the regional and national levels. These models offer innovative payment structure that enhances the delivery of primary care. This enables primary care physicians to focus on prioritizing the doctor-patient relationship, patients with chronic diseases, and improving healthcare outcomes.

Market Study

In 2019, general practice, family physician and geriatrics physicians segment generated the highest revenue share of over 40% due to increasing dependence on family physicians and general practitioners from Medicare beneficiaries. However, the general pediatric physician segment is projected to witness the fastest growth during the forecast period due to rising awareness among parents and increasing prevalence of chronic diseases in children.

In the U.S., family physicians are front-line caregivers to people from different socioeconomic backgrounds in urban and rural areas across the 50 states. One in every five office physician visits is made to a family physician which accounts for around 192 million visits annually. Family physicians are an integral part of the rural primary care system.

General Practice (GP) physicians have similar practices and patients as family physicians; however, they do not receive training on other subspecialties. General practitioners are skilled to treat all medical conditions and identify cases where patients require continuous care from a specialist. GPs are skilled to provide diagnosis and treatment of acute ailments to children and adults and initial treatment for chronic conditions

General internal medicine practitioners play an important role in controlling the expanding healthcare cost and implementing reforms in the primary healthcare system. In 2017, internal medicine physicians accounted for 34.5% of the total PCPs according to AMA physician masterfile and around 24 general internists were available per 100,000 Americans.

Some of the prominent players in the U.S. primary care physicians market include:

  • MDVIP

  • One Medical Group, Inc.

  • Rhode Island Primary Care Physicians Corporation (RIPCPC)

  • ChenMed LLC

  • DuPage Medical Group (DMG)

  • HealthCare Partners Medical Group

  • New West Physician

  • Crossover Health Medical Group

Market Segmentation

Type Outlook

  • General Practice, Family Physician and Geriatrics

  • General Internal Medicine

  • General Pediatrics

Report Detail

Proceed To Buy

USD 3500
USD 6000